Literature DB >> 1436691

Retinal ischemia induced by occlusion of both common carotid arteries in rats as demonstrated by electroretinography.

F Block1, M Schwarz, K H Sontag.   

Abstract

In 2 models of reduced cerebral blood flow-permanent occlusion of the vertebral arteries plus transient occlusion of the common carotid arteries (4VO) and transient clamping of the common carotid arteries (BCCA)-the acute effects on the electrical function of the retina were monitored by recording the photopic electroretinogram. During both 4VO and BCCA the amplitude of the b-wave was reduced. Within 30 min of reperfusion after 4VO and after BCCA the b-wave had fully recovered. In contrast, the a-wave was not affected by either treatment. The data suggest that occlusion of common carotid arteries leads to retinal ischemia and might represent a useful model of amaurosis fugax.

Entities:  

Mesh:

Year:  1992        PMID: 1436691     DOI: 10.1016/0304-3940(92)90731-l

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  20 in total

1.  Transient retinal artery occlusion: the potential utility and limitations of electroretinography.

Authors:  I H Yusuf; R Smith; C K Patel
Journal:  Eye (Lond)       Date:  2015-07-03       Impact factor: 3.775

2.  Control of retinal blood flow levels by selected combinations of cervical arterial ligations in rat.

Authors:  Norman P Blair; Sophie Leahy; Mahnaz Shahidi
Journal:  Exp Eye Res       Date:  2020-06-02       Impact factor: 3.467

3.  Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits.

Authors:  Joseph M Harrison; Randolph D Glickman; Charles S Ballentine; Yolanda Trigo; Melanie A Pena; Pearl Kurian; Laura K Najvar; Neeru Kumar; Ankit H Patel; William E Sponsel; John R Graybill; William C Lloyd; Margaret M Miller; Gianmarco Paris; Fernando Trujillo; Aaron Miller; Robert Melendez
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

4.  PACAP improves functional outcome in excitotoxic retinal lesion: an electroretinographic study.

Authors:  Balazs Varga; Krisztina Szabadfi; Peter Kiss; Eszter Fabian; Andrea Tamas; Monika Griecs; Robert Gabriel; Dora Reglodi; Adam Kemeny-Beke; Zsuzsanna Pamer; Zsolt Biro; Arpad Tosaki; Tamas Atlasz; Bela Juhasz
Journal:  J Mol Neurosci       Date:  2010-06-22       Impact factor: 3.444

Review 5.  Novel neuroprotective strategies in ischemic retinal lesions.

Authors:  Krisztina Szabadfi; Laszlo Mester; Dora Reglodi; Peter Kiss; Norbert Babai; Boglarka Racz; Krisztina Kovacs; Aliz Szabo; Andrea Tamas; Robert Gabriel; Tamas Atlasz
Journal:  Int J Mol Sci       Date:  2010-02-03       Impact factor: 6.208

6.  PACAP application improves functional outcome of chronic retinal ischemic injury in rats-evidence from electroretinographic measurements.

Authors:  Bese Danyadi; Krisztina Szabadfi; Dora Reglodi; Agoston Mihalik; Tibor Danyadi; Zsolt Kovacs; Istvan Batai; Andrea Tamas; Peter Kiss; Gabor Toth; Robert Gabriel
Journal:  J Mol Neurosci       Date:  2014-04-11       Impact factor: 3.444

7.  Preclinical models to investigate retinal ischemia: advances and drawbacks.

Authors:  Gillipsie Minhas; Ryuichi Morishita; Akshay Anand
Journal:  Front Neurol       Date:  2012-05-11       Impact factor: 4.003

8.  Immunohistochemical changes in rat retinas at various time periods of elevated intraocular pressure.

Authors:  María Hernandez; F David Rodriguez; S C Sharma; Elena Vecino
Journal:  Mol Vis       Date:  2009-12-10       Impact factor: 2.367

9.  Changes in retinal morphology, electroretinogram and visual behavior after transient global ischemia in adult rats.

Authors:  Ying Zhao; Bo Yu; Yong-Hui Xiang; Xin-Jia Han; Ying Xu; Kwok-Fai So; An-Ding Xu; Yi-Wen Ruan
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

10.  Distribution and protective function of pituitary adenylate cyclase-activating polypeptide in the retina.

Authors:  Tomoya Nakamachi; Attila Matkovits; Tamotsu Seki; Seiji Shioda
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-23       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.